Mayflower Financial Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $433K | Buy |
5,542
+1
| +0% | +$78 | 0.06% | 258 |
|
|
2025
Q1 | $402K | Sell |
5,541
-34
| -0.6% | -$2.46K | 0.06% | 258 |
|
|
2024
Q4 | $413K | Buy |
5,575
+68
| +1% | +$5.03K | 0.06% | 250 |
|
|
2024
Q3 | $363K | Sell |
5,507
-20
| -0.4% | -$1.32K | 0.05% | 264 |
|
|
2024
Q2 | $511K | Sell |
5,527
-31
| -0.6% | -$2.86K | 0.08% | 206 |
|
|
2024
Q1 | $531K | Buy |
+5,558
| New | +$531K | 0.09% | 202 |
|
|
2023
Q3 | – | Sell |
-2,471
| Closed | -$233K | – | 346 |
|
|
2023
Q2 | $233K | Buy |
2,471
+20
| +0.8% | +$1.89K | 0.03% | 314 |
|
|
2023
Q1 | $203K | Buy |
+2,451
| New | +$203K | 0.03% | 331 |
|
|
2022
Q3 | – | Sell |
-2,487
| Closed | -$236K | – | 345 |
|
|
2022
Q2 | $236K | Buy |
2,487
+12
| +0.5% | +$1.14K | 0.04% | 290 |
|
|
2022
Q1 | $291K | Buy |
2,475
+326
| +15% | +$38.3K | 0.04% | 274 |
|
|
2021
Q4 | $278K | Buy |
2,149
+4
| +0.2% | +$517 | 0.04% | 279 |
|
|
2021
Q3 | $247K | Sell |
2,145
-31
| -1% | -$3.57K | 0.03% | 288 |
|
|
2021
Q2 | $225K | Buy |
+2,176
| New | +$225K | 0.03% | 283 |
|